Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for treatment-resistant obsessive-compulsive disorder
IRCT2016020121745N1Phase 2Completed
- Sponsor
- Vice chancellor of research Shiraz University of Medical Sciences
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of duloxetine in obsessive compulsive disorder (OCD), sponsored by Vice chancellor of research Shiraz University of Medical Sciences. Started Jan 2016; status: completed.
02
Drugs
duloxetine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT2016020121745N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016020121745N1.